The 20 Best Graft Versus Host Disease (GvHD) Doctors Near Me in San Francisco, CA
Find the Top Graft Versus Host Disease (GvHD) Experts and Specialists
Office
Christopher Dvorak is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Dvorak is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Juvenile Myelomonocytic Leukemia (JMML), Hepatic Venoocclusive Disease with Immunodeficiency, Bone Marrow Transplant, and Splenectomy.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Aaron Logan is a Hematologist practicing medicine in San Francisco, California. Dr. Logan is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Aspiration, and Bone Marrow Transplant.
Dermatology Clinic At Mount Zion
Dr. John Koo is a dermatologist and director of the UCSF Psoriasis and Skin Treatment Center. Koo's research interests include psoriasis therapies, phototherapy, eczema, psychodermatology (the connection between mental stress and skin health) and quality of life issues. Koo earned his medical degree from Harvard University. He completed a residency in psychiatry at the University of California, Los Angeles, followed by a residency in dermatology at UCSF. Koo serves on the editorial board for the Journal of the American Academy of Dermatology. Dr. Koo is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Atopic Dermatitis, and Prurigo Nodularis. Dr. Koo is board certified in American Board Of Psychiatry And Neurology., Psychiatry and American Board Of Dermatology, Dermatology. Dr. Koo is currently accepting new patients.
Are you looking for a specific type of Graft Versus Host Disease (GvHD)?
Common conditions include: Chronic Graft Versus Host Disease (cGvHD)
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Charalambos (Babis) Andreadis specializes in bone marrow transplantation for adults and in treating Hodgkin's and non-Hodgkin's lymphoma, leukemia and multiple myeloma. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. His research, published widely in scientific journals, examines genetic and other factors that affect how patients respond to therapy, including degrees of drug toxicity. He also studies patient outcomes in these disorders. Andreadis earned his medical degree at Columbia University's Vagelos College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha Honor Medical Society in 1998. He completed a residency at New York-Presbyterian Hospital and a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. He also earned a master's degree in clinical epidemiology at the University of Pennsylvania, focusing on pharmacogenetics, the study of how genes impact an individual's response to medications. Dr. Andreadis is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Andreadis is board certified in American Board Of Internal Medicine/Hematology, Hematology and American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Andreadis is currently accepting new patients.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Neil Dunavin is an Oncologist practicing medicine in San Francisco, California. He has been practicing medicine for over 17 years. Dr. Dunavin is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.
The Periscope Group
Michael Albert is a primary care provider, practicing in Internal Medicine in San Francisco, California. He has been practicing medicine for over 10 years. Dr. Albert is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Nijmegen Breakage Syndrome, Wiskott-Aldrich Syndrome, Autosomal Dominant Hyper IgE Syndrome, Splenectomy, and Spinal Fusion.
Office
Justin Wahlstrom is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Wahlstrom is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Leukemia, and Bone Marrow Transplant.
Dr. Wilson Liao specializes in caring for patients with psoriasis and other skin disorders that may respond to phototherapy (exposure to ultraviolet light). Liao is interested in bringing cutting-edge research technologies into patient care in the clinic, a field called translational medicine. He is involved in a number of research studies on new therapies for psoriasis and skin cancer, and welcomes patient inquiries on study participation. Liao earned his medical degree at Harvard Medical School. He completed both his residency and fellowship in dermatology at UCSF. Dr. Liao is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Plaque Psoriasis, Atopic Dermatitis, Guttate Psoriasis, and Tissue Biopsy. Dr. Liao is board certified in American Board Of Dermatology, Dermatology.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Olin is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Olin is currently accepting new patients.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Catherine Smith is a hematologist-oncologist who cares for patients with acute leukemia and myeloproliferative neoplasms (blood cancers that occur when the body overproduces one of the blood cell types). She specializes in acute myeloid leukemia (also known as acute myelogenous leukemia or AML), a cancer of the blood and bone marrow that spreads rapidly. She has a particular interest in treating AML patients who have mutations in the FLT3 gene, which is involved in leukemia cell growth, division and survival and is a factor that may be useful in making a prognosis. Smith's research focuses on understanding why some patients do not respond to AML therapies and on developing new strategies to treat these patients. A San Francisco native, Smith earned her medical degree from Duke University and completed a residency in internal medicine at Brigham and Women's Hospital. She then completed a fellowship in hematology and oncology at UCSF. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Essential Thrombocythemia, Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Myelofibrosis, and Bone Marrow Aspiration. Dr. Smith is board certified in American Board Of Internal Medicine/Hematology, Hematology. Dr. Smith is currently accepting new patients.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Lawrence D. Kaplan, a hematologist-oncologist, directs UCSF's lymphoma program. He is an international leader in the treatment of lymphoma and HIV-associated lymphoma. In his research, Kaplan is particularly interested in developing new treatments for lymphoma and the HIV-related form of this cancer. Kaplan earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in medicine at Boston Medical Center and completed a fellowship in hematology and oncology at UCSF. He joined UCSF in 1985. Kaplan's professional activities include serving on the Lymphoma Working Group of the AIDS Malignancy Consortium, a clinical trials group supported by the National Cancer Institute (NCI). He formerly chaired the group's steering committee. He also serves on the lymphoma committee of Alliance for Clinical Trials in Oncology, a national research group sponsored by the NCI. Dr. Kaplan is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kaplan is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Kaplan is currently accepting new patients.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Martin is board certified in American Board Of Internal Medicine, Hematology. Dr. Martin is currently accepting new patients.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Karin Gaensler is a specialist in cancers of the blood who has a special interest in gene therapy. She is currently working to develop novel approaches for treating blood disorders caused by a specific gene mutation. Gaensler earned her medical degree from Harvard Medical School. She then went on to complete her residency in internal medicine and a fellowship in hematology and oncology at UCSF. Gaensler has received numerous awards, including a fellowship from the American Cancer Society, a fellowship from the Howard Hughes Medical Institute and a physician-scientist award from the National Institutes of Health. Dr. Gaensler is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Richter Syndrome, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gaensler is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology, American Board Of Internal Medicine/Hematology, Hematology, and American Board Of Internal Medicine, Internal Medicine. Dr. Gaensler is currently accepting new patients.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Peter Sayre specializes in adult bone marrow transplantation and other treatments for leukemia, multiple myeloma, lymphoma and Hodgkin's disease. Sayre is a director of clinical research at UCSF. His research interests focus on allogeneic stem cell transplants (which use cells from a matching donor) and leukemia in older adults. His work on these subjects has been widely published in medical and other scientific journals. Sayre earned an undergraduate degree in philosophy from Yale College, graduating magna cum laude. He earned his medical degree at the Rutgers Robert Wood Johnson Medical School, and he earned a doctorate in immunology at Harvard University. He completed a fellowship in hematology and oncology at UCSF before joining the faculty in 1996. Dr. Sayre is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sayre is board certified in American Board Of Internal Medicine/Hematology, Hematology. Dr. Sayre is currently accepting new patients.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Nina Shah is an Oncologist practicing medicine in San Francisco, California. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Lloyd Damon is an Oncologist practicing medicine in San Francisco, California. He has been practicing medicine for over 44 years. Dr. Damon is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 52 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
University Of California San Francisco
Biljana Horn is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Horn is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Hepatic Venoocclusive Disease with Immunodeficiency, Ataxia-Telangiectasia, Leukemia, and Bone Marrow Transplant.
University Of California San Francisco
Vanessa Kennedy is a Hematologist practicing medicine in San Francisco, California. She has been practicing medicine for over 10 years. Dr. Kennedy is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.
Haley Naik is a Dermatologist practicing medicine in San Francisco, California. Dr. Naik is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Hidradenitis Suppurativa, Bullous Pemphigoid, Pyoderma Gangrenosum, and Psoriasis. Dr. Naik is board certified in American Board Of Dermatology, Dermatology.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Michael Spinner is a Hematologist practicing medicine in San Francisco, California. Dr. Spinner is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Last Updated: 04/28/2026









